Most powerful obesity drug yet: People lost up to 25% of weight in trial
Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
Последние новости Programming от Tech News
Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
Public notice of a single "compassionate use" case is odd in every way.